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Abstract 
As per vital statistics of Gujarat, year by year mortality rate due to Respiratory 
System disorders is increasing which is also, one of the six major categories of death and on 
the 3
rd
 position. In age group 1-4 it is 2
nd
 major cause for death. Status is same for age group 
of 5-14 years. Majority of the patients are having present with recurrent cough as the 
manifestation of recurrent respiratory disease. Pathophysiology of Kasa almost exactly 
correlates the mechanism of cough reflex. In childhood age, Kasa may hamper the Growth 
and development, should be treated earlier. In rural India improper food habits and polluting 
cooking sources affect the pediatric health. While in urban India, congested population, air 
pollution, pampering in food habit of junk food affects pediatric health. Kasa is Kapha‑Vata 
dominant disorder and it is shown Vasa Avaleha help to decrease the rate of recurrence and 
symptoms quickly. With this aim, clinical study was undertaken on Kasa in sub-acute and 
chronic stage for duration of 4 weeks with follow-up of 4 weeks to see recurrence. The drug 
Vasa Avaleha was given orally with luke warm water. The results were highly significant on 
symptoms of Kasa. 
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Introduction 
Vital statistics of Gujarat shown 
year by year mortality rate due to 
Respiratory System disorders is increasing 
(1) as one of the six major categories (2) 
for death on the 3
rd
 position. The death due 
of Respiratory disorders in year 2010 is 
10.6% of the total. In age group 1-4 years 
it is 2
nd
 major cause (3) with same status 
for age group of 5-14 years (4).  
Cough is the most frequent 
symptom of respiratory diseases (5) while 
majority patients having recurrent cough 
as the manifestation of recurrent 
respiratory disease. In classics, 
descriptions of disease Kasa clearly 
correlate with cough and its 
pathophysiology exactly correlates the 
mechanism of cough reflex (6). Kapha is 
the main culprit in production of Kasa on 
the other hand it is dominating Dosha in 
childhood so the incidence is more in this 
age group. Early intervention is necessary 
in Kasa as it is a potential Nidanarthakara 
Vyadhi (causative factor for another 
disease) as can produce Kshaya(7). It is 
also important to treat any disease  in 
childhood period at the earliest as it may 
hamper the proper Vriddhi (growth and 
development) of child is clearly described 
by Acharya Charaka, that Avighata (dis-
interruption) as shareera vriddhikara 
bhava (growth and development factors) 
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i.e. Vighata (interruption) hinders 
Shareera Vriddhi (growth and 
development)(8).  
Acharya Vrundmadhava shown 
choice of drug for Kasa is Vasa (9). For 
that Vasa Avaleha polyherbal ayurvedic 
compound has been in use since ages, and 
found useful in treating respiratory 
disorders. Considering all these points the 
present work was taken with aim to 
evaluate the efficacy of Vasa Avaleha on 
Vataja, Pittaja and Kaphaja – Doshika 
Kasa in sub-acute and chronic stage. 
 
Materials and methods: 
The study was started after Ethical 
clearance by Institutional Ethics 
Committee, Vide: Ref- PGT/7-
A/Ethics/2012-2013/1964 dated on 
21/09/2012 and also registered in Clinical 
Trials Registry – India (CTRI). The 
registration number is 
CTRI/2013/03/003475 [Registered on: 
12/03/2013] - Trial Registered 
Retrospectively. Total 25 patients of 
Doshika variety of Kasa were registered 
from Outpatient Department of 
Kaumarbritya, Post Graduate Hospital, 
I.P.G.T. & R.A., Gujarat Ayurved 
University, Jamnagar. Out of 25 patients 
24 completed the prescribed course of 
treatment.  
 
Plan of study  
A simple open ended clinical trial 
with drug Vasa Avaleha (10) was planned. 
Ingredients and method of preparation of 
the drug is mentioned in Table 1 & Figure 
1 respectively. 
 
Table 1: Ingredients of Vasa Avaleha 
Sanskrit 
Name 
Botanical / 
English 
Name 
Parts 
Used 
Parts 
Vasa Adhatoda 
vasika Nees. 
Leaf 
(fresh) 
8 
Pippali Piper 
longum 
Linn. 
Fruits 
(Dry) 
1 
Go-ghrita Clarified 
butter 
- 1 
Madhu Honey - 4 
Sita Sugar candy - 4 
 
Figure 1: Method of preparation of 
Vasa Avaleha 
 
 
 
Dose was fixed according to 
Young’s rule: Adult dose (Child age / 
Child age + 12). Dose of Avaleha in 
classics is mentioned for adults is 1 Pala 
(48 g), so dose was fixed according to 
Young’s formula as compared to adult 
dose of Avaleha as 1 Pala (48 g). Dose as 
per age mentioned in Table 2.  
Table 2 – Dose as per age 
Age in 
Years 
Dose per 
day 
(Divided 
in 2 
doses) 
Age in 
Years 
Dose per 
day 
(Divided 
in 2 
doses) 
3 8 gm 8 16 gm 
4 10 gm 9 17 gm 
5 12 gm 10 18 gm 
6 13 gm 11 19 gm 
7 15 gm 12 20 gm 
Preparation of Vasa Swarasa as per 
standard procedure according to 
Sharangadhara madhyama khanda 
Adding of Sita in Vasa Swarasa and heated 
with Mandagni 
Till preparation of Sugar syrup of two 
threads consistency 
Addition of Go-Ghrita  after removing 
from the fire and allow to self cooling 
Addition of Pippali Churna and 
Continuous stirring 
Addition of honey after shelf 
cooling 
Vasa Avaleha 
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Time of administration was 
Abhakta (empty stomach) twice a day with 
Koshna Jala (Luke warm water). Duration 
of treatment was 4 weeks and follow up of 
4 weeks. Patients were given specific 
instruction on Pathyapathya (diet and 
lifestyle modification) as per the disease. 
 
Inclusion criteria  
Children of both sex belonging to 
age group 3 to 12 years, patient presenting 
with the classical symptoms of Kasa i.e. 
Shushka Kasa (dry cough), 
Peetanishthivana (yellow sputum), Sweta 
Kaphanishthivana (white sputum) etc. as 
per their Dosha variety (Vataja, Pittaja, 
Kaphaja) since 2 weeks.  
 
Exclusion criteria 
 Age below 3 years and above 12 
years, patient presenting with symptoms of 
Tamaka Shwasa (Bronchial asthma), 
Kshayaja & Kshataja Kasa, patient 
presenting with Pneumonia, COPD, 
Emphysema, Diphtheria, Pertusis, patient 
associated with systemic illness such as 
TB, HIV and any other chronic debilitating 
diseases.  
 
Investigations  
Routine blood examination 
[Hemoglobin % (Hb), Total White Blood 
Cells (TC), Differential Count (DC), 
Erythrocyte Sedimentation Rate (ESR)] 
and Absolute Eosinophil Count (AEC) 
were carried out in all the patients before 
initiate the administration of the drug and 
after completion of treatment. 
 
Assessment criteria  
 Subsidence of the clinical signs and 
symptoms i.e. Shushka Kasa (dry cough), 
Peetanishthivana (yellow sputum), Sweta 
Kaphanishthivana (white sputum), 
duration of bouts of cough, frequency of 
bouts of cough, rhonchi, crepitation etc; 
absence of recurrence during follow-up, 
changes in general health conditions, 
changes in hematological parameters. The 
result in the clinical study was analyzed on 
24 patients by applying paired student ‘t’ 
test on all the signs and symptoms 
mentioned in assessment criteria. The 
difference of individual score SD was 
calculated with Standard Error in Mean 
(SEM). These data are shown as Mean ± 
SEM, to quantify the percentage of 
improvement in each patients, it was 
calculated using the formula (BT-
AT)/BT*100 except Sharira Upachaya 
(Body weight) and Hb%, for these two 
parameters formula was (AT-BT)/AT*100. 
Symbol “↑” show value is increase and “↓” 
for value is decrease. Values in tables 
<0.05 show statistically significant and 
<0.001 statistically highly significant 
results. 
 
Effect of therapy  
In each patients’ individual 
statistical analysis, results less than 25% as 
unchanged, 26 to 50% as mild positive 
response, 51 to 75% as moderate positive 
response, 76 to 99% as marked positive 
response and 100% as cured, complete 
remission of signs and symptoms were 
evaluated. 
 
 
Observations & Results: 
Table 3: Effect on the symptoms of disease Kasa 
 
Features 
Features n BT AT % 
relief 
±  
SD 
±  
SEM 
t P 
 
 
 
Vataja 
Shushka Kasa 
(dry cough) 
8 1.25 0.00 100 0.46 0.16 7.63 <0.001 
Parshwashoola 
(pain in sides of chest) 
8 1.00 0.00 100 0.00 0.00 - <0.001 
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Kasa Shirahshoola 
(headache) 
8 1.25 0.12 90 0.83 0.29 3.81 <0.001 
Swarabheda 
(hoarseness of voice) 
15 1.00 0.00 100 0.00 0.00 - <0.001 
Shushka-ura,kantha, 
vaktra 
(dryness in chest, throat 
and mouth) 
7 1.00 0.00 100 0.00 0.00 - <0.001 
Daurbalya (weakness) 21 1.04 0.04 95.45 0.21 0.00 - <0.001 
 
 
Pittaja 
Kasa 
Peetanishthivana 
(yellow sputum) 
12 1.16 0.08 92.85 0.28 0.08 13.00 <0.001 
Moha (stupor) 7 1.00 0.00 100 0.00 0.00 - <0.001 
Daaha 
(burning sensation) 
6 1.00 0.00 100 0.00 0.00 - <0.001 
Jwara (fever) 22 1.00 0.00 100 0.00 0.00 - <0.001 
 
 
 
 
Kaphaja 
Kasa 
Swetakaphanishthivana 
(white sputum) 
17 1.47 0.11 92 0.49 0.11 11.32 <0.001 
Mandagni (suppression 
of digestive power) 
18 1.11 0.11 90 0.34 0.08 12.36 <0.001 
Aruchi (anorexia) 19 1.05 0.21 80 0.50 0.11 7.32 <0.001 
Peenasa (rhinitis) 16 1.00 0.06 93.75 0.25 0.06 15.00 <0.001 
Kaphapoornavaksha 
(fullness of chest with 
cough) 
10 1.10 0.10 90.90 0.47 0.14 6.70 <0.001 
 
 The drug had provided relief in all the cardinal and associated symptoms of Kasa 
irrespective of their Doshika presentations. All the changes on effect on symptoms of 
Doshika Kasa were statistically highly significant. 
 
Table 4: Effect on the signs of disease Kasa 
Features n BT AT % 
relief 
± SD ± 
SEM 
t P 
Bouts of cough-Duration 24 1.91 0.20 89.13 0.46 0.09 18.02 <0.001 
Bouts of cough-Frequency 24 1.91 0.20 89.13 0.46 0.09 18.02 <0.001 
Sleep disturbance 8 1.00 0.00 100 0.00 0.00 - <0.001 
Fever 22 1.00 0.00 100 0.00 0.00 - <0.001 
Crepitation 7 1.00 0.00 100 0.00 0.00 - <0.001 
Rhonchi 13 1.00 0.00 100 0.00 0.00 - <0.001 
 
Fever, crepitation and rhonchi are the indicators of infection to lower respiratory. 
Result in these parameters shown drug efficacy on the infectious conditions. The results were 
statistically highly significant.  
 
Table 5: Effect on Aaturabala 
Features n BT AT % 
relief 
±  
SD 
±  
SEM 
t P 
Abhyavaranashakti 
(capacity of food intake) 
24 1.87 0.41 77.77 0.65 0.13 10.85 <0.001 
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Jaranashakti (capacity of 
digestive power) 
24 1.87 0.41 77.77 0.65 0.13 10.85 <0.001 
Ruchi hi aaharakale 
(appreciation of taste at 
time of food) 
22 1.13 0.09 92 0.37 0.08 13.07 <0.001 
Bala vridhi (increase in 
strength) 
20 1.35 0.25 81.48 0.30 0.06 15.98 <0.001 
Sharira Upachaya 
(body weight) 
24 19.29 19.89 3.03↑ 0.65 0.13 4.51 <0.001 
Swaravarnayoga (texture, 
luster and voice) 
19 1.05 0.10 90 0.40 0.09 10.20 <0.001 
Activity 24 1.75 0.83 52.38 0.71 0.14 6.26 <0.001 
Nindralabhoyathakalam 
(adequate sleep at night) 
14 1.07 0.07 93.33 0.00 0.00 - <0.001 
Vaikarikaranam cha 
swapnanamadarshanam 
(Absence of pathological 
dreams) 
9 1.00 0.11 88.88 0.33 0.11 8.00 <0.001 
 
All results were statistically highly significant. Abhyavaranashakti (capacity of food 
intake), Jaranashakti (capacity of digestive power) and Ruchi hi aaharakale (appreciation of 
taste at the time of food) are the parameters for Agni Bala (digestive power strength). All 
these changes might due to Dipana –Pachana property of Pippali and Go-ghrita.  
Balavriddhi (increase in strength) and Swaravarnayoga (texture, luster and voice), body 
weight and activity are parameters for Dehabala (physical strength). The drug might build 
immunity due to Rasayana (rejuvenation) effect on Pranavaha srotas. 
Nindralabhoyathakalam (adequate sleep at night) and Vaikarikaranam cha 
swapnanamadarshanam (absence of discomfort dreams) are parameters for Satva Bala 
(mental strength). Satva bala (mental strength) is very much related to the counseling of the 
patients during the treatment. Improvement in sleep may be due to decreased symptoms of 
Kasa. 
 
 
Table 6: Effect on hematological parameters 
Features n BT AT % 
relief 
± 
 SD 
±  
SEM 
t P 
Hb% 24 10.88 11.29 3.57↑ 0.78 0.16 2.52 <0.05 
T.C. 24 8566.6 9570.8 11.71↑ 2621.7 535.1 1.87 >0.05 
 
 
D.C. 
Neutrophiles 24 45.5 47.6 4.67↑ 10.86 2.21 0.95 >0.05 
Eosinophiles 24 4.58 5.25 14.55↑ 2.88 0.58 1.13 >0.05 
Lymphocytes 24 47.33 45.75 3.34↓ 10.25 2.09 0.75 >0.05 
Monocytes 22 2.63 2.40 8.62↓ 0.97 0.20 1.09 >0.05 
ESR 24 12.50 13.91 11.33↑ 14.60 2.98 0.47 >0.05 
AEC 24 397.9 510.4 28.27↑ 263.44 53.77 2.09 <0.05 
 On Hb% significant changes was found. Increase in Hb% shown built up immunity 
towards specific disease and its associated conditions. The parameters ESR and AEC indicate 
the action on allergic conditions while TC and polymorphs indicate infectious conditions. 
Drug didn’t found much effective as these parameters as compare to subjective parameters. 
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Table 7: Overall effect of treatment on subjective and objective parameters 
 n BT AT % change  ±  
SD 
 ± 
SEM 
t P 
Overall effect 24 99.69 13.76 85.93↓ 43.67 5.33 16.10 <0.001 
Overall effect of treatment in was 85.93% percentages, which was statistically highly 
significant it shown the drug having all the properties required to break the manifestation of 
Kasa. 
 
Table 8: Individual overall effect on subjective and objective parameters 
Zones based on % relief Number of patients % 
Cured (100 %) 00 00 
Marked positive response (76 - 99 %) 02 8.33 
Moderate positive response (51 – 75%) 18 75 
Mild positive response (26 – 50 %) 04 16.67 
Unchanged (0 – 25%) 00 00 
Total 24 100 
 
Individualized overall effect of therapy were considered highest number of patient 
(75%) got Moderate positive response, 8.33% got Marked positive response, and Mild 
positive response in 16.67% of patients. In the present disease condition, till date there is no 
definite known cure (11). So any sort of improvement in the overall condition is fairly 
acceptable.  
 
Table 9: Effect on recurrence of symptoms of Kasa 
Recurrence during 
follow-up 
n No event (%) Less frequency and intensity (%) 
24 75 25 
 
75% of the patients had no recurrence of the symptoms during the follow up period 
while 25% of the patients had recurrence but with lesser frequency and intensity may be due 
to Rasayana (rejuvenation) effect of the drug on Pranavaha srotas and preventive qualities to 
the disease.  
 
 
Discussion 
Kasa has been considered as a 
disease in Ayurveda with elaborate 
description of separate etiology, 
pathogenesis, premonitory symptoms, 
signs with symptoms and treatment (12). 
The disease Kasa explained in Classics 
includes many of the upper and lower 
respiratory disease as it is evident by the 
vast collection of signs and symptoms. The 
diseases of systems other than respiratory 
system are dealt as the symptom Kasa 
described at the context of respective 
diseases. Since the Kasa is a Vata - Kapha 
dominated disease, its incidence should be 
witnessed more during the childhood, 
which is normal time of Kapha 
dominance. In addition to above data the 
description of the Samprapti 
(manifestation) of Kasa almost exactly 
correlates the mechanism of cough 
reflex.(13, 14)Thus beyond doubt Kasa 
can be considered as ‘Cough’ in modern 
terms. 
Cough is a symptom of underlying 
disease in modern medicine, it is the reflex 
generated predominantly by the receptors 
located in the respiratory tree. Patient 
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presenting with cough at first draws the 
attention of physician towards respiratory 
system and many times the pathology is 
located within upper or lower respiratory 
tract.(15) Respiratory tract infections are 
most common infection and thus recurrent 
Kasa (Recurrent respiratory Tract 
Infections) is considered as the indicator of 
decreased Vyadhikshamatva (Immunity 
against specific disease) or Bala (strength) 
or Ojas (assence of dhatu) or 
Immunity.(16) 
In modern perspective Shushka 
Kasa (dry cough) and Shirahshoola 
(headache) can be co-related to allergic 
conditions whereas Swarabheda (hoarse 
voice) indicates the infection with 
involvement of larynx(17) as occurs in 
many of viral CROUP (Laryngo-
tracheobronchitis), Daurbalya (weakness) 
is also more common in infectious 
conditions rather than in allergy. 
Peetanishthivana (yellow colour sputum) 
by tradition has been considered as the 
purulent sputum in cases of acute 
infections, one should very cautiously 
differentiate the proportions of mucoid 
part and the purulent part of it. Even the 
Kaphaja Kasa may be infective in origin. 
The initial phases of viral upper respiratory 
infection (viz. Sinusitis, Pharyngitis or 
Tonsilitis) present with Kaphaja 
symptoms (Shirogaurava, Mandajwara, 
Praseka, Anannabhilasha etc.)(18).  
Majority of the times different 
Doshika symptoms manifest during the 
course of a single disease such as upper 
respiratory tract manifestation of allergic 
etiology may show Vataja symptoms for 
few days later modify itself to a Kaphaja 
or Pittaja based upon the course of the 
disease. If allergic inflammation reached 
the sinuses to block the Ostia then 
secretions collect there and present with 
Kaphaja symptoms for next few days, if 
they not resolved it may get infected by the 
opportunistic pathogens and may cause 
fulminate sinusitis or rhino-sinusitis which 
then is definitely a Pittaja disorder. 
Dvandvaja (dominancy of two Dhosha) 
presentations manifest during transient 
phases. The results support the hypothesis 
that Vasa Avaleha may be effective in all 
the types of Kasa irrespective of Doshika 
variants. Even though it effective in all 
types of Kasa. 
When the child suffers from 
recurrent Kasa there is chances of 
developing the complications such as 
severe lower respiratory infections (LRTI -
Pneumonia etc), hyper reactive airway 
diseases (HRAD), leads to nutritional 
deprivation and hampered growth. In 
Astanga Sangraha it is described that on 
long run Kasa leads to Oja (assence of 
dhatu), Bala (strength) and Mamsa 
Kshaya(19) (loss of mamsa dhatu). Thus 
the situation warrants an immediate insight 
deep in to the matter with timely 
intervention. 
Avaleha form (20) indicated in 
obstruction in flow of Prana Vayu due to 
vitiated Kapha which the main factor to 
produce Kasa. Deepana-Pachana 
properties of the drug will help by kindling 
the Jatharagni as well as Rasagni and 
Bhutagni. Furthermore, the Shothahara 
Karma neutralize the Srotorodha in 
Pranavaha Srotas due to Shotha 
(inflammation) created by Saama Khapa 
and Aama which stop natural flow of Vata.  
 
Probable mode of action 
The Dosha Prashamana effect 
(Vasa, Pippali, Madhu) acts on the main 
Doshas which contribute to the Samprapti 
(manifestation of disease), viz. Vata and 
Kapha while in Go-ghrita Tridoshahara 
properties are present. Deepana-Pachana 
Karma (Pippali, Go-grhita) digest Aama. 
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Srotoshodhana and Chhedana property of 
Madhu remove Saama Kapha and Aama 
and help in Vatanulomana property 
(Pippali,Sita) maintains the normal flow of 
Vata. Drugs indicated in Shwasa, Kasa 
and Peenasa (Vasa, Pippali, Madhu) also 
act on the symptoms. Avaleha may work 
as Rasayana (rejuvenation) for the 
Pranavaha Srotas and also shows Kapha-
Vatahara effect. The pharmacological 
studies already reported on the individual 
drugs also favour its effect in Respiratory 
Tract Diseases as given below: 
 
Anti-bacterial (21) - Vasa 
Immunostimulatory(22) - Pippali 
Anti-asthamatic(23) - Pippali 
Anti-microbial (24, 25) - Vasa, Pippali 
Anti-allergic (26) - Pippali 
Immunomodulatory(27) - Pippali  
Anti-tussive (28) - Vasa 
Bronchodilator (29) - Vasa  
Anti-inflammatory (30) – Vasa 
Antioxidant (31, 32) - Vasa, Madhu 
 
Conclusion 
Vasa Avaleha showed statistically 
highly significant result on most of the 
signs and symptoms of all type of Doshika 
Kasa. On Aturabala (strength of the 
patient) statistically highly significant 
results were found. The drug had not 
shown much effect on hematological 
parameter as compare to subjective 
parameters. The drug might build 
immunity due to rejuvenation effect on 
Pranavaha srotas as observed by low 
recurrence rate during follow-up. On 
overall effect, highly significant result is 
found which is highly promising and 
encouraging for more explorations of its 
kind in future. 
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